未来十年内性别多样性人群中的癌症病例可能翻倍
Cancer cases among trans people could more than double in the next decade, study warns
一项由伦敦玛丽女王大学领导的研究预测,未来十年内英国性别多样性人群中的癌症病例可能翻倍。研究指出,需加强癌症筛查、专业培训和数据收集,以应对这一变化。
A study led by Queen Mary University of London has found that the number of new cancer cases each year among transgender and gender-diverse people in England could more than double over the next decade.
The research, published in eClinicalMedicine, estimates that approximately 965 new cancer cases occur annually among transgender and gender-diverse people in England. This figure is projected to rise to around 1,739 cases in five years and 2,257 cases within 10 years.
The researchers indicate that the findings highlight the need for cancer services to prepare for the changing needs of this population, alongside improvements in cancer screening, health care professional training and the collection of patient data.
The study, believed to be the first to estimate the annual number of cancer cases among transgender and gender-diverse people in England, combined national cancer statistics, population data and existing research on the potential effects of gender-affirming health care.
Breast cancer was estimated to be the most common cancer in this population, accounting for approximately 19% of cases, followed by colorectal cancer at 12% and lung cancer at 11%.
Despite growing recognition of the health care needs of transgender and gender-diverse people, reliable national data on cancer incidence in this population remain limited.
Current cancer registration systems do not consistently distinguish between sex characteristics and gender identity, making it difficult to accurately understand cancer patterns and plan appropriate services.
Transgender and gender-diverse people may also face barriers to cancer screening and treatment, including concerns about discrimination, health care environments that do not meet their needs, and uncertainty about eligibility for screening programs.
Potential impact of gender-affirming care
The researchers also examined how access to gender-affirming care, including hormone treatment and surgery, could influence future cancer cases.
Their modeling suggests that if transgender and gender-diverse people were able to access the gender-affirming care they planned to receive, the projected number of annual cancer cases in 10 years could be approximately 11% lower, falling to 2,006.
This is because different types of gender-affirming care have previously been found to affect the likelihood of developing certain cancers, with a reduction in breast cancer among trans men, prostate cancer among trans women, and ovarian, uterine and cervical cancers following relevant surgeries.
Breast cancer has been shown to be more common among trans women receiving feminizing hormone therapy, but the incidence is still lower than for cisgender women.
The researchers stress that these findings are based on estimates and modeling rather than directly observed outcomes.
Dr. Alison Berner, lead author of the study and clinical senior lecturer in medical oncology at Queen Mary, said, "Our research suggests that the number of cancer cases among transgender and gender-diverse people in England could more than double over the next decade. This highlights an important and often overlooked area of cancer care. As this population ages, we need to ensure cancer services are prepared to meet patients' needs and that everyone can access appropriate screening, diagnosis and treatment."
Dr. Chloe Pasin, co-lead author and postdoctoral researcher at Queen Mary, said, "Cancer care is not one-size-fits-all. Our findings suggest that gender-affirming treatments could reduce the likelihood of developing some cancers, while potentially increasing the risk of others. Understanding these differences is essential to care. But we also need better data to build a clearer picture of cancer risks among transgender and gender-diverse people and make sure their needs are not overlooked."
The study team hopes that these findings will help inform future cancer service planning, workforce training and screening policies, and highlight the need for more nuanced data collection in health care.
Publication details
Chloe Pasin et al., Estimation of cancer cases in transgender and gender diverse people in England: a simulation and projection study, eClinicalMedicine (2026). DOI: 10.1016/j.eclinm.2026.104342
Journal information: EClinicalMedicine
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Cancer cases among trans people could more than double in the next decade, study warns (2026, November 19) retrieved 19 November 2026 from https://medicalxpress.com/news/2026-11-cancer-cases-trans-people-decade.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com